Dr. Martens PLC (STU:3U2)

€ 0.89 0 (0%) Market Cap: 850.28 Mil Enterprise Value: 1.28 Bil PE Ratio: 25.57 PB Ratio: 2.13 GF Score: 62/100

Half Year 2025 Dr Martens PLC Earnings Call Transcript
Nov 28, 2024

€0.77 (+11.59%)

Earnings
Full Year 2024 Dr Martens PLC Earnings Presentation Transcript
May 30, 2024
Q3 2023 Dr Martens PLC Trading Statement Call Transcript
Jan 25, 2024
Half Year 2024 Dr Martens PLC Earnings Call Transcript
Nov 30, 2023

€0.965 (-25.77%)

Earnings
Full Year 2023 Dr Martens PLC Earnings Call Transcript
Jun 01, 2023

€1.64 (-6.82%)

Earnings
Q4 2023 Dr Martens PLC Trading Statement Call Transcript
Apr 14, 2023
Q3 2022 Dr Martens PLC Trading Statement Call Transcript
Jan 19, 2023
Half Year 2023 Dr Martens PLC Earnings Call Transcript
Nov 24, 2022

€3.24 (-1.82%)

Earnings
Full Year 2022 Dr Martens PLC Earnings Call Transcript
Jun 01, 2022

€3.04 (+18.75%)

Earnings
Q3 2022 Dr Martens PLC Trading Statement Call Transcript
Jan 27, 2022
Half Year 2022 Dr Martens PLC Earnings Presentation Transcript
Dec 09, 2021
Full Year 2021 Dr Martens PLC Earnings Presentation Transcript
Jun 17, 2021

Q3 2022 Dr Martens PLC Trading Statement Call Transcript

Jan 19, 2023 / 08:00AM GMT

Release Date Price: €1.65 (-30.08%)

Transcript

Operator

Good morning, and welcome to Dr. Martens FY 2023 Q3 trading update. My name is Harry, and I'll be coordinating your call today. (Operator Instructions)

I would now like to hand you over to Kenny Wilson, CEO, to begin. Kenny, please go ahead.

Kenny Wilson

Dr. Martens plc - CEO

Thank you very much. Good morning, everyone. And firstly, a big thank you for joining our Q3 results call at such short notice.

We've obviously accelerated this call due to a significant reduction to our FY 2023 forecast. This is something that I'm extremely disappointed about. This disappointment is even greater because a large part of our miss should have been within our control, and it is a people and process failure.

Due to a large operational challenge in our new Los Angeles distribution center and weaker-than-expected DTC trading in the United States, we now expect full-year revenue growth of 11% to 13% on an actual currency basis and full-year EBITDA between GBP250 million and GBP260 million. We are also reducing guidance for FY 2024, which Jon will

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.